Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy. (Q46396991)
Jump to navigation
Jump to search
scientific article published on 23 November 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy. |
scientific article published on 23 November 2011 |
Statements
Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy (English)
Ruihua Zhao
Jiannan Wu
Weijuan Jia
Chang Gong
Fengyan Yu
Zefang Ren
Kai Chen
23 November 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference